Quantum Computing Inc. Common
QUBT
$9.63
-7.93%
Quantum Computing Inc. is a technology company focused on developing and delivering machines for quantum computing, reservoir computing, and remote sensing applications based on integrated photonics and non-linear quantum optics. The company positions itself as a niche player aiming to commercialize room-temperature, low-power quantum systems at an affordable cost, targeting high-performance computing, AI, and cybersecurity markets. The current investor narrative is intensely speculative, driven by a sector-wide rally in quantum computing stocks fueled by news of accelerated industry timelines and technological breakthroughs, such as Nvidia's AI model for quantum error correction, which has ignited significant hype and FOMO, as noted in recent headlines, despite ongoing debates about the sustainability of valuations given the company's minimal revenue and pre-commercial stage.…
QUBT
Quantum Computing Inc. Common
$9.63
Related headlines
Investment Opinion: Should I buy QUBT Today?
Rating: Sell. The core thesis is that QUBT's valuation is a speculative bubble completely untethered from its financial fundamentals, making it highly likely to disappoint investors seeking growth at a reasonable price.
Supporting evidence is overwhelming: the stock trades at a trailing PS ratio of 2,474.6x against negligible revenue, it is deeply unprofitable with a net margin of -27.38%, and it burns cash aggressively with -$36.98M in TTM free cash flow. While one analyst projects future revenue of $1.48B, this serves only to highlight the immense execution gap, not provide a credible valuation anchor. The stock's 44.88% decline over six months, despite a recent speculative bounce, underscores its deteriorating trend.
The thesis would be invalidated only if QUBT demonstrates a sudden, sustainable, and massive ramp in revenue to justify its valuation, such as consecutive quarters of revenue exceeding $10 million while moving towards profitability. A downgrade to a Strong Sell would be warranted on a breakdown below the $6.18 support level. Conversely, a shift to Hold would require evidence of a credible path to profitability and a significant de-rating in the PS multiple. Based on current data, the stock is egregiously overvalued relative to its financial reality and peerless in its risk profile.
Sign up to view all
QUBT 12-Month Price Forecast
The AI assessment is strongly bearish based on a catastrophic mismatch between valuation and fundamentals. The stock prices in perfection—multi-billion dollar revenue—while the company delivers losses on minimal sales. The recent 38.7% monthly bounce is viewed as a classic speculative rally within a longer-term downtrend (-44.88% over 6 months), not a change in fundamentals. High confidence stems from the objective, extreme nature of the financial metrics. The stance would only upgrade to neutral if the PS multiple collapses by over 90% and the company demonstrates a clear, funded path to positive gross margins. Until then, the risk of a precipitous fall to reflect its pre-revenue status is paramount.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Quantum Computing Inc. Common's 12-month outlook, with a consensus price target around $12.52 and implied upside of +30.0% versus the current price.
Average Target
$12.52
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$8 - $13
Analyst target range
Analyst coverage is extremely limited, with only one analyst providing estimates, indicating this is a small-cap, speculative stock with minimal institutional research interest, which typically leads to higher volatility and less efficient price discovery. The single analyst projects an average EPS of $1.90 and average revenue of $1.48 billion for an unspecified future period, but no consensus price target or recommendation distribution is available, making it impossible to calculate implied upside or gauge sentiment; the wide range between the low revenue estimate of $1.22 billion and high of $1.76 billion signals significant uncertainty about the company's commercial prospects. The institutional ratings data shows a pattern of maintained 'Buy' ratings from firms like Rosenblatt and Ascendiant Capital alongside a 'Neutral' from Cantor Fitzgerald, but the lack of price targets and the recent exit of a major institutional investor (Anson Funds) per news snippets suggest deep underlying skepticism about the company's near-term ability to monetize its technology, reinforcing the high-risk nature of the investment.
Bulls vs Bears: QUBT Investment Factors
The evidence strongly favors the bear case. While speculative momentum and a strong balance sheet provide short-term support, the core investment thesis is undermined by an astronomical valuation (PS of 2,474.6x) built upon virtually no revenue, severe and consistent losses, and a complete dependence on external funding. The most important tension in the debate is between the market's wildly optimistic, forward-looking revenue projections of $1.48 billion and the company's present reality of sub-$200k quarterly sales and negative gross margins. The resolution of this tension—whether QUBT can achieve even a fraction of that projected growth before cash runs out—will determine if the stock is a moonshot or a mirage.
Bullish
- Sector Rally & Speculative Momentum: The stock has surged 38.70% over the past month, significantly outperforming the S&P 500's 9.98% gain, driven by a sector-wide rally in quantum computing. This momentum, fueled by news like Nvidia's AI model for quantum error correction, suggests strong speculative interest and potential for further near-term gains if the hype persists.
- Strong Liquidity & Minimal Debt: The company boasts a fortress-like balance sheet with a current ratio of 102.38 and a negligible debt-to-equity ratio of 0.001. This financial safety net, funded by $718.6 million in recent equity issuance, provides ample runway to fund its R&D-heavy operations without near-term solvency risk.
- Analyst Projections for Massive Growth: The sole covering analyst projects average future revenue of $1.48 billion, representing a monumental leap from the current quarterly revenue of $198k. This forward-looking optimism, while speculative, underpins the market's valuation and provides a narrative for explosive growth if commercialization succeeds.
- Recent Revenue Growth from Low Base: Q4 2025 revenue of $198k represents a 119.35% year-over-year growth, albeit from an extremely low base. This demonstrates some commercial traction is beginning, though the multi-quarter trend remains highly volatile and inconsistent.
Bearish
- Astronomical Valuation with No Profit: The stock trades at a trailing Price-to-Sales (PS) ratio of 2,474.6x, an unsustainable premium that implies near-perfect execution of multi-billion dollar revenue forecasts. With negative net income and a gross margin of -49.49% in Q4 2025, the valuation is completely disconnected from current financial reality.
- Minimal Revenue & Severe Cash Burn: The company is in a pre-revenue stage with erratic quarterly sales (ranging from $39k to $384k) and is burning cash aggressively, with TTM free cash flow of -$36.98 million and Q4 2025 operating cash flow of -$11.02 million. It is entirely dependent on dilutive equity financing to fund operations.
- Deep Unprofitability & Negative Margins: The company is fundamentally unprofitable, with a net income of -$1.56 million in Q4 2025 and an operating margin of -74.89%. The gross margin of -49.49% indicates it currently loses money on every dollar of sales, highlighting a broken business model at its current scale.
- High Volatility & Institutional Skepticism: With a beta of 3.665, the stock is 266% more volatile than the market, making it a high-risk holding. This is compounded by the exit of a major institutional investor (Anson Funds) and limited analyst coverage (only one), signaling deep skepticism about near-term monetization prospects.
QUBT Technical Analysis
The stock is in a pronounced downtrend over the longer term, evidenced by a 44.88% decline over the past six months, yet it has experienced a dramatic short-term reversal with a 38.70% surge over the past month. Currently trading at $9.21, the price sits at approximately 35.6% of its 52-week range (between $6.18 and $25.84), indicating it remains significantly depressed from its highs despite the recent bounce, which could represent either a value opportunity or a temporary relief rally in a still-falling market. The recent momentum is sharply positive and diverges from the longer-term downtrend, with the 1-month gain of 38.70% vastly outperforming the 3-month loss of -0.65%, suggesting a potential trend reversal or a powerful short squeeze, especially given the stock's extreme volatility as indicated by its beta of 3.665. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $25.84 and strong support at the 52-week low of $6.18; a sustained breakout above recent highs near $15 would signal a more durable recovery, while a breakdown below $6.18 would confirm the resumption of the bear market, with the stock's beta of 3.665 indicating it is approximately 266% more volatile than the broader market, making it a high-risk, high-reward proposition for traders.
Beta
3.70
3.70x market volatility
Max Drawdown
-74.4%
Largest decline past year
52-Week Range
$6-$26
Price range past year
Annual Return
+36.0%
Cumulative gain past year
| Period | QUBT Return | S&P 500 |
|---|---|---|
| 1m | +42.2% | +11.0% |
| 3m | +2.1% | +5.9% |
| 6m | -25.1% | +9.0% |
| 1y | +36.0% | +30.4% |
| ytd | -12.5% | +7.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QUBT Fundamental Analysis
Revenue is minuscule and highly erratic, with the most recent quarterly figure at $198,000, representing a YoY growth of 119.35% from a very low base, but the multi-quarter trend shows extreme volatility, from $39,000 in Q1 2025 to $384,000 in Q3 2025, indicating the business is in a pre-revenue, R&D-heavy stage with no consistent commercial traction. The company is deeply unprofitable, with a net income of -$1.56 million in Q4 2025 and a gross margin of -49.49% for that quarter, though this improved from a gross margin of -24.67% in Q1 2025, highlighting severe margin compression and a fundamental inability to generate profit from its minimal sales, with operating expenses consistently dwarfing revenue. The balance sheet shows a strong liquidity position with a current ratio of 102.38 and minimal debt (debt-to-equity of 0.001), but this is fueled by equity issuance, as evidenced by $718.6 million in financing cash flow from stock sales in Q4 2025; however, the company is burning cash at an alarming rate, with free cash flow of -$36.98 million TTM and an operating cash flow of -$11.02 million in Q4 2025, indicating it is entirely dependent on external financing to fund its operations and growth.
Quarterly Revenue
$198000.0B
2025-12
Revenue YoY Growth
+2.19%
YoY Comparison
Gross Margin
-0.49%
Latest Quarter
Free Cash Flow
$-36984000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QUBT Overvalued?
Given the company's negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is an astronomical 2,474.6x, while the forward PS ratio is not explicitly provided but implied to be extremely high given analyst revenue estimates of $1.48 billion for a future period, which would still result in a significant premium; the gap between the current negligible revenue and these massive forward estimates underscores the market's speculative growth expectations. Peer comparison is challenging due to the lack of industry average data in the provided valuation set, but the stock's PS ratio of 2,474.6x is stratospherically high by any reasonable standard, indicating a massive premium that is only justifiable if the company achieves explosive, multi-billion dollar revenue growth in the near future, a scenario currently unsupported by its financials. Historically, the stock's own valuation has been extreme and volatile, with its PS ratio reaching 84,417.6x as of Q4 2025; the current PS of 2,474.6x, while lower, remains near the upper end of its own historical spectrum for a company with virtually no sales, suggesting the market continues to price in wildly optimistic expectations for commercial success.
PE
-90.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -268x~310x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-69.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are extreme. The company operates with a fundamentally unprofitable model, evidenced by a Q4 2025 gross margin of -49.49% and an operating margin of -74.89%. It is burning cash at an alarming rate, with TTM free cash flow of -$36.98 million, and is entirely reliant on dilutive equity sales (evidenced by $718.6M in financing cash flow) to fund operations, posing a severe risk of further shareholder dilution. Revenue is minuscule ($198k last quarter) and highly volatile, indicating no consistent commercial traction and high operational execution risk.
Market & Competitive Risks are pronounced. The stock trades at a stratospheric PS ratio of 2,474.6x, representing extreme valuation compression risk if the speculative quantum computing hype fades or if the company fails to meet growth expectations. Its beta of 3.665 indicates it is hypersensitive to broader market sentiment and sector rotations. Competitive disruption is a constant threat from larger, better-funded players like Microsoft, which has its own accelerated quantum roadmap, potentially rendering QUBT's niche technology obsolete.
Worst-Case Scenario involves a collapse of the speculative quantum narrative combined with a failure to achieve meaningful revenue milestones. This could trigger a mass exodus of retail investors, leading to a re-rating towards a valuation more reflective of its current financials—a pre-revenue R&D company. The realistic downside could see the stock retesting its 52-week low of $6.18, representing a potential loss of approximately -33% from the current price of $9.21. In a severe bear case where funding dries up, the risk of significant further dilution or even insolvency cannot be ruled out.
FAQ
The key risks are, in order of severity: 1) Valuation Collapse Risk: The extreme PS ratio of 2,474.6x could compress violently if growth expectations falter. 2) Funding & Dilution Risk: With TTM free cash flow of -$36.98M, the company must continually raise capital, likely through dilutive stock sales. 3) Execution Risk: Transitioning from $198k in quarterly revenue to analyst projections of $1.48B is a monumental leap with a high probability of failure. 4) Market Risk: The stock's beta of 3.665 makes it highly volatile and sensitive to sector sentiment shifts, as seen in recent news labeling quantum stocks a 'bubble'.
The 12-month outlook presents three scenarios. The Base Case (50% probability) sees the stock trading between $7 and $12 as speculative hype fades and the company fails to justify its valuation, aligning with a continued pre-commercial narrative. The Bear Case (35% probability) projects a drop to the $6.18 - $7 range if the bubble bursts or funding issues arise. The Bull Case (15% probability) envisions a rally to $20-$25.84 on a major commercial breakthrough. The Base Case is most likely, centered on the company's ongoing struggle to bridge the gap between its current finances and market expectations.
QUBT is profoundly overvalued by any conventional metric. Its trailing Price-to-Sales ratio of 2,474.6x is astronomical and implies the market is pricing in near-perfect success in commercializing its technology to generate over $1.48 billion in revenue. Compared to its own financials—negative gross margins and minimal sales—the valuation is completely disconnected from reality. The stock trades at a massive premium not justified by current operations, making it vulnerable to severe multiple compression.
For the vast majority of investors, QUBT is not a good stock to buy. It represents an extreme risk/reward proposition, with a valuation (PS ratio of 2,474.6x) that requires flawless execution of billion-dollar revenue forecasts from a base of just $198k per quarter. The high probability of further dilution, consistent losses, and sector volatility (beta of 3.665) make it a speculative gamble, not an investment. It might only be suitable for a tiny portion of a very aggressive trader's portfolio as a high-risk speculation on quantum computing hype.
QUBT is unsuitable for traditional long-term investment due to its lack of earnings, cash flow, and proven business model. Its extreme volatility (beta 3.665) and dependency on speculative sentiment make it a vehicle only for very short-term trading by experienced speculators who can actively monitor news and technical levels. There is no dividend, and earnings visibility is near zero. Any position should be considered with a very short horizon (weeks or months, not years), and investors must be prepared to exit quickly on deteriorating technicals or negative news.